Colorectal Cancer Molecular Diagnostics Global Market Opportunities And Strategies To 2034
상품코드:1880710
리서치사:The Business Research Company
발행일:2025년 11월
페이지 정보:영문 359 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 대장암 분자진단 시장은 2024년 약 25억 6,091만 달러의 규모에 이르렀으며, 2019년 이후 6.54%의 연평균 복합 성장률(CAGR)로 성장해 왔습니다. 이 시장은 2024년 25억 6,091만 달러에서 2029년 38억 2,729만 달러로 8.37%의 성장률로 확대될 것으로 예측됩니다. 그 후 2029년 이후는 CAGR 7.85%로 성장을 계속해 2034년에는 55억 8,553만 달러에 이를 전망입니다.
대장암 분자진단은 대장암과 관련된 특정 분자 변화를 검출하도록 설계된 진단 기술 및 도구의 범주를 의미합니다. 이러한 변화는 유전자 변이, 마이크로 위성 불안정성, DNA(데옥시리보 핵산) 메틸화 패턴을 포함하며, 질병의 거동을 이해하고 임상 판단에 정보를 제공하는 데 매우 중요합니다. 이러한 진단 기술은 스크리닝의 정확성 향상, 진단 확정, 치료 전략의 입안, 질병의 진행 및 재발 모니터링에 중심적인 역할을 합니다.
맞춤형 의료로의 전환
이 역사적인 기간에 있어서, 대장암 분자진단 시장은 주로 맞춤형 의료로의 이행에 의해 견인되어 왔습니다. 획일적인 치료 전략에서 환자 고유의 유전자, 분자, 바이오마커 프로파일을 기반으로 한 개별화된 진단 및 치료 접근법으로의 전환은 대장암(CRC) 치료의 정확성과 치료 성적을 향상시켰습니다. 개인화된 의료는 표적 요법의 적절한 매칭, 부작용 완화, 자원의 효율적인 활용을 가능하게 합니다. 예를 들어 2022년 10월 시점에서 과학자, 환자, 의료 제공업체를 대표하는 미국 조직 '맞춤형 의료 연합(Personalized Medicine Coalition)'의 추계에 의하면, 복수 유형의 암, 유전성 희귀질환, 각종 만성 질환·감염증 환자용으로, 7만 5,000유형 이상의 유전자 검사 제품과 300유형의 맞춤형 의료 따라서 맞춤형 의료로의 이행이 대장암 분자진단 시장의 성장을 견인했습니다.
재택 대장암 검진 키트의 보급 확대
대장암 분자진단 시장의 주요 기업은 편리성 향상과 정기적인 암 검진 프로그램에의 참가 촉진을 목적으로 한 가정용 스크리닝 키트의 발매와 확대에 주력하고 있습니다. 이러한 노력은 의료기관에 대한 통원이나 침습적 처치와 같은 장벽의 저감을 도모함과 동시에 의료서비스가 미치지 못한 층에 대한 액세스 확대를 목표로 하고 있습니다. 예를 들어, 2024년 3월에는 미국을 거점으로 하는 정밀 종양학 기업인 가드 앤트 헬스사가, 가정용으로 이용 가능한 최초의 혈액 기반의 대장암 스크리닝 검사 「Shield」를 발매했습니다. Shield는 개인이 임상 환경 밖에서 시료를 채취할 수 있게 하여 컴플라이언스를 향상시키고 채용을 확대합니다. 환자 중심의 접근성을 강조함으로써 가드 앤트 헬스는 암의 조기 발견률을 높이고 비침습적 진단 시장에서 자사의 지위를 강화하는 것을 목표로 하고 있습니다.
세계의 대장암 분자진단 시장은 대기업이 시장을 견인하는 집중 상태에 있습니다. 2024년 기준에서 상위 10개 기업이 시장 전체의 49.36%를 차지했습니다.
목차
제1장 주요 요약
대장암 분자진단 - 시장의 매력과 거시경제 환경
제2장 목차
제3장 표 일람
제4장 그림 일람
제5장 보고서 구성
제6장 시장 특징
일반적인 시장의 정의
개요
대장암 분자진단 시장 정의와 세분화
시장 세분화 : 유형별
기기
시약 및 키트
서비스
시장 세분화 : 기술별
중합효소 연쇄반응(PCR)
염기서열 분석
질량 분석법
전사 매개 증폭
칩 및 마이크로어레이
등온 핵산 증폭 기술(INAAT)
현장 하이브리다이제이션(FISH/ISH)
면역조직화학(IHC)
최종 사용자별 시장 세분화
병원
외래수술센터(ASC)
진단 실험실
재택치료 환경
기타 최종 사용자
제7장 주요 시장 동향
혈액 검사에 의한 대장암 검진의 확대
자택용 대장암 검진 키트의 도입 확대
대장암 검사에 있어서 완전 자동화 PCR 플랫폼의 도입
제8장 세계의 대장암 분자진단 시장 성장 분석 및 전략 분석 프레임워크
세계의 대장암 분자진단 PESTEL 분석
정치
경제
사회
기술
환경
법적
최종 이용 산업의 분석
병원
외래수술센터(ASC)
진단 검사 기관
재택치료 환경
기타 최종 사용자
세계의 대장암 분자진단 시장 : 성장률 분석
시장 성장 실적(2019-2024년)
시장 성장 촉진요인(2019-2024년)
시장 성장 억제요인(2019-2024년)
시장 성장 예측(2024-2029년, 2034년)
예측 성장 요인/기여 요소
정량적 성장 요인
성장 촉진요인
성장 억제요인
세계의 대장암 분자진단 시장 : 전체 시장 규모(TAM)
제9장 세계의 대장암 분자진단 시장 : 세분화
세계의 대장암 분자진단 시장 : 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 대장암 분자진단 시장 : 기술별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 대장암 분자진단 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 대장암 분자진단 시장 : 기기 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 대장암 분자진단 시장 : 시약 및 키트 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 대장암 분자진단 시장 : 서비스별 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
제10장 대장암 분자진단 시장 : 지역 및 국가별 분석
세계의 대장암 분자진단 시장 : 지역별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 대장암 분자진단 시장 : 국가별, 분석과 예측(2019-2024년, 2029년, 2034년)
제11장 아시아태평양 시장
제12장 서유럽 시장
제13장 동유럽 시장
제14장 북미 시장
제15장 남미 시장
제16장 중동 시장
제17장 아프리카 시장
제18장 경쟁 구도와 기업 프로파일
기업 프로파일
F. Hoffman-La Roche Ltd
Exact Sciences Corporation
Illumina Inc
Qiagen NV
Guardant Health Inc
제19장 기타 주요 기업 및 혁신 기업
Thermo Fisher Scientific
Danaher Corporation
Hologic Inc.
Agilent Technologies
Quest Diagnostics Incorporated
Siemens Healthineers
Biomerieux SA
Grifols SA
Sysmex Corporation
Abbott Laboratories
Labcorp Holdings Inc.
Strand Life Sciences
Geneoscopy
Karkinos Healthcare
Novigenix
제20장 경쟁 벤치마킹
제21장 경쟁 대시보드
제22장 주요 인수합병(M&A)
New Day Diagnostics LLC, Epigenomics AG 자산 인수
New Day Diagnostics LLC, EDP Biotech Corporation과 합병
제23장 대장암 분자진단에서의 최근 동향
대장암 모니터링을 위한 분자 잔존 병변(MRD) 검사의 개발
차세대 대장암 스크리닝 검사의 개시
제24장 기회와 전략
세계의 대장암 분자진단 시장(2029년) : 새로운 기회를 제공하는 국가
세계의 대장암 분자진단 시장(2029년) : 새로운 기회를 제공하는 부문
세계의 대장암 분자진단 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제25장 대장암 분자진단 시장 : 결론과 제안
결론
권고
제품
장소
가격
프로모션
사람들
제26장 부록
KTH
영문 목차
영문목차
Colorectal cancer molecular diagnostics refers to a category of diagnostic technologies and tools designed to detect specific molecular alterations associated with colorectal cancer. These alterations include gene mutations, microsatellite instability and DNA (Deoxyribonucleic Acid) methylation patterns, which are critical for understanding disease behavior and informing clinical decisions. These diagnostics play a central role in enhancing the accuracy of screening, confirming diagnoses, guiding treatment strategies and monitoring for disease progression or recurrence.
The global colorectal cancer molecular diagnostics market reached a value of nearly $2,560.91 million in 2024, having grown at a compound annual growth rate (CAGR) of 6.54% since 2019. The market is expected to grow from $2,560.91 million in 2024 to $3,827.29 million in 2029 at a rate of 8.37%. The market is then expected to grow at a CAGR of 7.85% from 2029 and reach $5,585.53 million in 2034.
Shift Towards Personalized Medicine
During the historic period, the colorectal cancer molecular diagnostics market mainly driven by a shift towards personalized medicine. The move away from one-size-fits-all treatment strategies toward tailored diagnostic and therapeutic approaches based on patient-specific genetic, molecular and biomarker profiles enhanced precision and outcomes in colorectal cancer (CRC) care. Personalized medicine enables better matching of targeted therapies, reduction in adverse effects and more efficient use of resources. For instance, in October 2022, according to the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Therefore, the shift towards personal medicine drove the growth of the colorectal cancer molecular diagnostics market.
Growing Adoption Of At-Home Colorectal Cancer Screening Kits
Major players in the colorectal cancer molecular diagnostics market are focusing on the launch and expansion of at-home screening kits designed to improve convenience and encourage greater participation in regular cancer screening programs. These initiatives are aimed at reducing barriers such as clinic visits and invasive procedures, while also expanding access to underserved populations. For instance, in March 2024, Guardant Health, a US-based precision oncology company, launched Shield, its first blood-based colorectal cancer screening test available for at-home use. Shield enables individuals to collect samples outside clinical settings, thereby improving compliance and broadening adoption. By emphasizing patient-centered accessibility, Guardant Health aims to increase early cancer detection rates and strengthen its position in the non-invasive diagnostics market.
The global colorectal cancer molecular diagnostics market is concentrated, with large players operating the market. The top ten competitors in the market made up to 49.36% of the total market in 2024.
Colorectal Cancer Molecular Diagnostics Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global colorectal cancer molecular diagnostics market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for colorectal cancer molecular diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The colorectal cancer molecular diagnostics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider colorectal cancer molecular diagnostics market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by technology and by end users.
Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis:- Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation: - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by technology and by end users in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies:- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
Competitive Dashboard: - Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments:- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for colorectal cancer molecular diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups
Appendix:- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type: Instruments; Reagents And Kits; Services
2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT); In Situ Hybridization (FISH/ISH); Immunohistochemistry (IHC)
3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings; Other End Users
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; colorectal cancer molecular diagnostics indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table of Contents
1 Executive Summary
1.1 Colorectal Cancer Molecular Diagnostics - Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Colorectal Cancer Molecular Diagnostics Market Definition And Segmentations
8.7 Global Colorectal Cancer Molecular Diagnostics Total Addressable Market (TAM)
9 Global Colorectal Cancer Molecular Diagnostics Market Segmentation
9.1 Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10 Colorectal Cancer Molecular Diagnostics Market, Regional and Country Analysis
10.1 Global Colorectal Cancer Molecular Diagnostics Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Colorectal Cancer Molecular Diagnostics Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Investments
11.9.11 Major Companies
11.10 China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Major Companies
11.20 Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
11.33.1 Country Information
11.33.2 Market Information
11.33.3 Background Information
11.33.4 Government Initiatives
11.33.5 Regulations
11.33.6 Regulatory Bodies
11.33.7 Major Associations
11.33.8 Taxes Levied
11.33.9 Corporate Tax Structure
11.33.10 Major Companies
11.34 South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Colorectal Cancer Molecular Diagnostics Market: Country Analysis
12.7 UK Market
12.8 UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 France Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Major companies
13.3 Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Colorectal Cancer Molecular Diagnostics Market: Country Analysis
13.7 Russia Market
13.8 Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Colorectal Cancer Molecular Diagnostics Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Major Companies
14.16 Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Colorectal Cancer Molecular Diagnostics Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape And Company Profiles
18.1 Company Profiles
18.2 F. Hoffman-La Roche Ltd
18.2.1 Company Overview
18.2.2 Products And Services
18.2.3 Business Strategy
18.2.4 Financial Overview
18.3 Exact Sciences Corporation
18.3.1 Company Overview
18.3.2 Products And Services
18.3.3 Business Strategy
18.3.4 Financial Overview
18.4 Illumina Inc
18.4.1 Company Overview
18.4.2 Products And Services
18.4.3 Business Strategy
18.4.4 Financial Overview
18.5 Qiagen N.V.
18.5.1 Company Overview
18.5.2 Products And Services
18.5.3 Business Strategy
18.5.4 Financial Overview
18.6 Guardant Health Inc
18.6.1 Company Overview
18.6.2 Products And Services
18.6.3 Business Strategy
18.6.4 Financial Overview
19 Other Major And Innovative Companies
19.1 Thermo Fisher Scientific
19.1.1 Company Overview
19.1.2 Products and Services
19.2 Danaher Corporation
19.2.1 Company Overview
19.2.2 Products and Services
19.3 Hologic Inc.
19.3.1 Company Overview
19.3.2 Products and Services
19.4 Agilent Technologies
19.4.1 Company Overview
19.4.2 Products and Services
19.5 Quest Diagnostics Incorporated
19.5.1 Company Overview
19.5.2 Products and Services
19.6 Siemens Healthineers
19.6.1 Company Overview
19.6.2 Products and Services
19.7 Biomerieux SA
19.7.1 Company Overview
19.7.2 Products and Services
19.8 Grifols S.A.
19.8.1 Company Overview
19.8.2 Products and Services
19.9 Sysmex Corporation
19.9.1 Company Overview
19.9.2 Products and Services
19.10 Abbott Laboratories
19.10.1 Company Overview
19.10.2 Products and Services
19.11 Labcorp Holdings Inc.
19.11.1 Company Overview
19.11.2 Products and Services
19.12 Strand Life Sciences
19.12.1 Company Overview
19.12.2 Products and Services
19.13 Geneoscopy
19.13.1 Company Overview
19.13.2 Products and Services
19.14 Karkinos Healthcare
19.14.1 Company Overview
19.14.2 Products and Services
19.15 Novigenix
19.15.1 Company Overview
19.15.2 Products and Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 New Day Diagnostics LLC Acquired Assets Of Epigenomics AG
22.2 New Day Diagnostics LLC Merged With EDP Biotech Corporation
23 Recent Developments In Colorectal Cancer Molecular Diagnostics
23.1 Development Of Molecular Residual Disease (MRD) Tests For Colorectal Cancer Monitoring
23.2 Launch Of Next-Generation Colorectal Cancer Screening Test
24 Opportunities And Strategies
24.1 Global Colorectal Cancer Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
24.2 Global Colorectal Cancer Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
24.3 Global Colorectal Cancer Molecular Diagnostics Market In 2029 - Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Colorectal Cancer Molecular Diagnostics Market, Conclusions And Recommendations
